PubMed HealthSearch

Biomedical subjects

Y H Yoon

Publications and source records attributed to Y H Yoon.

5 recordsLinked to original sources

Breakthrough time and adsorption capacity of respirator cartridges.

A model developed in previous studies was applied to investigate the respirator cartridge contaminant breakthrough of 121 different chemical compounds. Included in this set of 121 contaminants are representative examples of various types of organic compounds, (e.g., acetates, ketones, aromatics, alcohols, amines, alkanes, chlorinated hydrocarbons). Intrinsic to the model are two important parameters, k' (a rate constant) and tau (50% breakthrough time). Values of the two parameters pertinent to an assault concentration of 1000 ppm were determined for each of the 121 organic compounds. These values were used to calculate the breakthrough time at specified fractional breakthrough as well as the respirator cartridge loading capacity under various conditions. An approach was presented that permits the determination of contaminant loading capacity (on carbon) as a function of breakthrough time at a specified assault concentration. The effect of contaminant assault concentration on the saturation capacity was investigated for various combinations of nine different compounds and three different types of respirator cartridges. Calculated saturation capacity data derived from application of the model compare favorably (+/- 5%) with corresponding experimental data. Saturation capacities calculated by using the model addressed in this study were compared with corresponding results previously calculated by others using the Dubinin adsorption isotherm.

Acetates

A theoretical model for respirator cartridge service life for binary systems: application to acetone/styrene mixtures.

A theoretical model, developed previously to assess respirator cartridge service life, was applied to various acetone/styrene binary assault systems. Experimental data, collected for several binary mixtures differing only with respect to the concentration of each of the two compounds, were interpreted in terms of the model. Styrene concentrations varied from 228 to 1578 ppm; the range of acetone concentrations was 92-985 ppm. The specific influence of the compound assault concentrations on respirator cartridge service life was carefully characterized, as break-through curves were generated for both acetone and styrene for each of several different binary systems. Specifically, experimental data for each system were used to determine values of the following theoretical parameters: k'1, tau 1, k'2, tau 2, and Am. These parameters were employed with the theory to generate complete theoretical breakthrough curves and to determine the time-dependence of the weight of each compound adsorbed by the respirator cartridge carbon bed. An interesting phenomenon observed for the acetone/styrene systems was the displacement (from the carbon) of previously adsorbed acetone molecules by styrene molecules. Acetone breakthrough was observed first in each of the systems studied. Following the onset of this breakthrough, the acetone breakthrough concentration was enhanced by the displacement of acetone from the carbon bed by the adsorption of styrene. The theoretical model accurately predicts both this enhancement and the associated breakthrough characteristics of styrene. In addition, the theory is capable of predicting the ratio of the number of displaced acetone molecules to the corresponding number of displacing styrene molecules. For these studies, this ratio ranged from 0.3 to 0.7. The service life of respirator cartridges exposed to acetone/styrene mixtures depends on the assault concentration of each compound and is significantly influenced (shortened) by the displacement phenomenon.

Acetone

Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs.

In acute and subacute toxicological studies, amphotericin B methyl ester was shown to be much less toxic than the parent antibiotic. As a single intravenous dose in mice, the methyl ester was approximately 20 times less toxic than amphotericin B. Also, the acute toxicity of the methyl ester in mice was not enhanced by the presence of chemically induced hepatic or renal damage or by the concurrent administration of amphotericin B or flucytosine. In a 1-month intraperitoneal study in rats, the methyl ester was about one-fourth as nephrotoxic as amphotericin B. In a 1-month intravenous study in dogs, the methyl ester was about one-eighth as nephrotoxic and one-fourth to one-half as hepatotoxic as the parent compound. In addition, the methyl ester, unlike amphotericin B, produced minimal renal effects, which did not increase in severity with increasing dosage. Based on the results of these studies, it is concluded that amphotericin B methyl ester has the potential for an improved therapeutic ratio in the treatment of systemic mycoses.

Amphotericin B